Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Juan Samper (Valencia, Spain), C. Sabater Abad (Valencia, Spain), S. Torres Martinez (Valencia, Spain), E. Fernández-Fabrellas (Valencia, Spain), V. Jaimes Diaz (Valencia, Spain), E. Verdejo Mengual (Valencia, Spain), S. Calabuig Fariñas (Valencia, Spain). Angiogenesis in idiopathic pulmonary fibrosis. 828

Member's Comments

No comment yet.

Related content which might interest you: Angiogenesis in experimental pulmonary fibrosis Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 Pirfenidone in idiopathic pulmonary fibrosis Source: Eur Respir J 2010; 36: 695-696 Year: 2010 Pirfenidone in idiopathic pulmonary fibrosis Source: Eur Respir J 2010; 35: 821-829 Year: 2010 Pulmonary hypertension in idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Role of midkine in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Accelerated ageing in idiopathic pulmonary fibrosis and pulmonary hypertension Source: International Congress 2018 – Accelerated ageing in lungs Year: 2018 Idiopathic pulmonary fibrosis Source: Eur Respir Monogr 2013; 62: 37-53 Year: 2013 Idiopathic pulmonary fibrosis Source: School Course 2014 - Interstitial lung diseases Year: 2014 Idiopathic pulmonary fibrosis Source: Eur Respir Monogr 2015; 68: 50-63 Year: 2015 Idiopathic pulmonary fibrosis Source: International Congress 2018 – State of the art session: Interstitial lung diseases Year: 2018 Exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2016 – Russia Session Year: 2016 PP217 – Modeling idiopathic pulmonary fibrosis on a lung-on-chip Source: ERS Lung Science Conference 2021 Year: 2021 A first step against idiopathic pulmonary fibrosis Source: Eur Respir Rev 2011; 20: 130-131 Year: 2011 Angiogenesis and coagulation in the development of pulmonary hypertension in idiopathic interstitial pneumonias (IIP) Source: Eur Respir J 2005; 26: Suppl. 49, 540s Year: 2005 Role of JAK2/STAT3 pathway in vascular function of pulmonary fibrosis patients Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Pulmonary hypertension in patients with idiopathic pulmonary fibrosis Source: Eur Respir Mon 2012; 57: 148-160 Year: 2012 Antifibrotic choice in idiopathic pulmonary fibrosis Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018 Subtypes of pulmonary emphysema on HRCT affect prognosis on combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Imaging of idiopathic pulmonary fibrosis Source: International Congress 2016 – Russia Session Year: 2016 Sildenafil inhibit dose-dependently profibrotic and remodelling effects of TGFbeta1 on pulmonary arteries from patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014